VTGN
USDVistagen Therapeutics Inc. Common Stock
$2.220-0.090 (-3.896%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Key Metrics
Market Metrics
Open
$2.310
High
$2.340
Low
$2.215
Volume
0.01M
Company Fundamentals
Market Cap
67.5M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.15M
Exchange
NCM
Currency
USD
52-Week Range
Low $1.9Current $2.220High $4.96
Related News
BusinessWire
Vistagen to Present at the 2025 Anxiety and Depression Association Conference
Posters Highlight New Insights into Social Anxiety Disorder Vistagen (NASDAQ:VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a
View more
Related Stocks
GJS
Goldman Sachs Group Securities STRATS Trust for Goldman Sachs Group Securities Series 2006-2
NASDAQ
Finance: Consum...
HIW
Highwoods Properties Inc.
NASDAQ
Real Estate Inv...
MFICL
MidCap Financial Investment Corporation 8.00% Notes due 2028
NASDAQ
Finance/Investo...
BE
Bloom Energy Corporation
NASDAQ
Industrial Mach...
ICCH
ICC Holdings Inc.
NASDAQ
Property-Casual...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.